Synergistic effect between colistin and bacteriocins in controlling gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2719-2725

  Naghmouchi, Karim ^a,b   Baah, John ^b   Hober, Didier ^c   Jouy, Eric ^d   Rubrecht, Cédric ^c   Sané, Famara ^c   Drider, Djamel ^e  

^a LETHBRIDGE RESEARCH CENTRE   (Canada)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c University Lille   (France)

^d Anses Ploufragan Plouzane Laboratory Genetique Virale et Biosecurite   (France)

^e UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; COLISTIN; NISIN; PEDIOCIN;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; COMET ASSAY; CYTOLYSIS; DNA DAMAGE; DRUG POTENTIATION; EPITHELIUM CELL; ESCHERICHIA COLI; GENOTOXICITY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; VERO CELL; YERSINIA ENTEROCOLITICA;

ANIMALS; BACTERIOCINS; CERCOPITHECUS AETHIOPS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; EPITHELIAL CELLS; ESCHERICHIA COLI O157; GRAM-NEGATIVE BACTERIA; HEMOLYSIS; HUMANS; KIDNEY; LEUKOCYTES; NISIN; VERO CELLS;

EID: 84877865975     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02328-12     Document Type: Article

References (38)

1. Falagas ME, Kasiakou SK. 2005. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
2. Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A, Forrest A, Bulitta JB, Tsuji BT. 2010. Resurgence of colistin: A review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 30: 1279-1291.
3. Landman D, Georgescu C, Martin DA, Quale J. 2008. Polymyxins revisited. Clin. Microbiol. Rev. 21:449-465.
4. Kaye KM, Kaye D. 2005. Polymyxins (polymyxin B and colistin), p 435-436. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Churchill Livingstone, Philadelphia, PA.
5. Lopes J, Inniss WE. 1969. Electron microscopy of effect of polymyxin on Escherichia coli lipopolysaccharide. J. Bacteriol. 100:1128-1130.
6. Martin NI, Moake MM, Churey JJ, Whittal R, Worobo RW, Vederas JC. 2003. Isolation, structural characterization, and properties of mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M. J. Biol. Chem. 278:13124-13132.
7. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. 1998.-Lactamases responsible for resistance to expandedspectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42:1350-1354.
8. Corvec S, Furustrand Tafin U, Betrisey B, Borens O, Trampuz A. 2013. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-lactamase-producing Escherichia coli in a foreignbody infection model. Antimicrob. Agents Chemother. 57:1421-1427.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
10. Wolf CE, Gibbons WR. 1996. Improved method for quantification of the bacteriocin nisin. J. Appl. Bacteriol. 80:453-457.
11. Naghmouchi K, Drider D, Baah J, Teather R. 2010. Nisin A and polymyxin B as synergistic inhibitors of Gram-positive and Gram-negative bacteria. Probiotics Antimicrob. Protiens 2:98-103.
12. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition (M7-A7). Clinical and Laboratory Standards Institute, Wayne, PA.
13. Naghmouchi K, Belguesmia Y, Baah J, Teather R, Drider D. 2011.
14. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli. Res. Microbiol. 162:99-107.
15. Jaju M, Ahuja YR. 1983. Cytogenetic effect of colistin on human lymphocytes in vitro: Chromosome aberrations, sister chromatid exchanges, mitotic index, cell cycle kinetics, and acrocentric associations. Teratog. Carcinog. Mutagen. 3:515-526.
16. Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:184-191.
17. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35:206-221.
18. Malagoli M. 2007. A full-length protocol to test hemolytic activity of palytoxin on human erythrocytes. Invertebr. Surviv. J. 4:92-94.
19. Clinical and Laboratory Standards Institute. 2012 Performance Standards for Antimicrobial Susceptibility Testing: 22nd Informational Supplement (M100-S22) Clinical and Laboratory Standards Institute, Wayne, PA.
20. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement (M100-S22). Clinical and Laboratory Standards Institute, Wayne, PA.
21. Drider D, Rebuffat S. 2011. Prokaryotic antimicrobial peptides: From genes to applications. Springer, New York, NY. 20. Leikoski N, Fewer DP, Sivonen KK. 2009. Widespread occurrence and lateral transfer of the cyanobactin biosynthesis gene cluster in cyanobacteria. Appl. Environ. Microbiol. 75:853-857.
22. Leikoski N, Fewer DP, Jokela J, Alakoski P, Wahlsten M, Sivonen K. 2012. Analysis of an inactive cyanobactin biosynthetic gene cluster leads to discovery of new natural products from strains of the genus Microcystis. PLoS One 7:e43002. doi:10.1371/journal.pone.0043002.
23. Wang H, Fewer DP, Sivonen KK. 2011. Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria. PLoS One 6:e22384. doi:10.1371/journal.pone.0022384.
24. Goldstein BP, Wei J, Greenberg K, Novick R. 1998. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J. Antimicrob. Chemother. 42:277-278.
25. Giacometti A, Cirioni O, Barchiesi F, Scalise G. 2000. In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. Diagn. Microbiol. Infect. Dis. 38:115-118.
26. Bartoloni A, Mantella A, Goldstein BP, Dei R, Benedetti M, Sbaragli S, Paradisi F. 2004. In-vitro activity of nisin against clinical isolates of Clostridium difficile. J. Chemother. 16:119-121.
27. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D. 2012. Ready for a world without antibiotics? The pensières antibiotic resistance call to action. Antimicrob. Resist. Infect. Control 14:1-11.
28. Wareham DW, Gordon NC, Hornsey M. 2011. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 66:1047-1051.
29. Hornsey M, Longshaw CC, Phee L, DW Wareham DW. 2012. In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens. Antimicrob. Agents Chemother. 56:3080-3085.
30. Ried C, Wahl C, Miethke T, Wellnhofer G, Landgraf C, Schneider-Mergener J, Hoess A. 1996. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus antilipopolysaccharide factor. J. Biol. Chem. 271:28120-28127.
31. Belguesmia Y, Madi A, Sperandio D, Merieau A, Feuilloley M, Prévost H, Drider D, Connil N. 2011. Growing insights into the safety of bacteriocins: The case of enterocin S37. Res. Microbiol. 162:159-163.
32. Paiva AD, Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. 2012. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol on bacteriocin activity. Microbiology 158: 2851-2858.
33. Ostling D, Johanson KJ. 1984. Microelectrophoretic study of radiationinducedDNAdamages in individual mammalian cells. Biochem. Biophys. Res. Commun. 123:291-298.
34. Hartmann A, Speit GG. 1995. Genotoxic effect of chemicals in the single cell gel (SCG) test with human blood cells in relation to the induction of sister chromatid exchanges. Mutat. Res. 346:49-56.
35. Collins AR, Duthie SJ, Dobson VL. 1993. Direct enzyme detection of endogenous oxidative base damage in human lymphocytic DNA. Carcinogenesis 14:1733-1735.
36. Ostling D, Johanson KJ. 1987. Bleomycin, in contrast to gamma irradiation, induces extreme variation of DNA strand breakage from cell to cell. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 52:683-691.
37. McKelvey-Martin VJ, Green MHL, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A. 1993. The single cell gel electrophoresis assay (comet assay): A European review. Mutat. Res. 288:47-63.
38. Fairbairn DW, Olive PL, O'Neill KL. 1995. The comet assay: A comprehensive review. Mutat. Res. 339:37-59.